Related Experiment Video
Updated: Jun 16, 2026
Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA1
Published on: February 17, 2011
BRCA gene structure and function in tumor suppression: a repair-centric perspective
Conleth G Murphy1, Mary Ellen Moynahan
1Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center, New York City, NY 10065, USA.
Abstract:
Germline mutations in the BRCA1 and BRCA2 genes are characterized by deficient repair of DNA double-strand breaks by homologous recombination. Defective DNA double-strand break repair has been not only implicated as a key contributor to tumorigenesis in mutation carriers but also represents a potential target for therapy. The transcriptional similarities between BRCA1-deficient tumors and sporadic tumors of the basal-like subtype have led to the investigation of homologous recombination repair-directed therapy in triple-negative tumors, which demonstrates overlap with the basal-like subtype. We broaden the scope of this topic by addressing a "repair-defective" rather than "BRCA1-like" phenotype. We discuss structural and functional aspects of key repair proteins including BRCA1, BRCA2, BRCA1 interacting protein C-terminal helicase 1, and partner and localizer of BRCA2 and describe the phenotypic consequences of their loss at the cellular, tissue, and organism level. We review potential mechanisms of repair pathway dysfunction in sporadic tumors and address how the identification of such defects may guide the application of repair-directed therapies.
Insights
Defective DNA repair, particularly homologous recombination, drives cancer in BRCA mutation carriers and offers therapeutic targets. This study explores repair-defective phenotypes beyond BRCA mutations for broader cancer treatment strategies.
Area of Science:
- Molecular Biology
- Genetics
- Oncology
Background:
- Germline mutations in BRCA1 and BRCA2 genes impair homologous recombination repair of DNA double-strand breaks.
- Defective DNA repair is a significant factor in tumorigenesis and a potential therapeutic target.
- BRCA1-deficient tumors share transcriptional similarities with basal-like sporadic tumors, suggesting homologous recombination repair-directed therapy for triple-negative breast cancers.
Purpose of the Study:
- To broaden the understanding of cancer therapy by focusing on a general "repair-defective" phenotype.
- To discuss the structural and functional roles of key homologous recombination repair proteins.
- To review mechanisms of repair pathway dysfunction in sporadic tumors and guide therapy development.
Main Methods:
- Review of structural and functional aspects of BRCA1, BRCA2, and associated proteins (e.g., BARD1, PALB2).
- Analysis of phenotypic consequences of repair protein loss at cellular, tissue, and organism levels.
- Examination of potential mechanisms of homologous recombination repair pathway dysfunction in sporadic cancers.
Main Results:
- Detailed discussion of key homologous recombination repair proteins and the cellular, tissue, and organismal impacts of their dysfunction.
- Identification of potential mechanisms driving repair pathway defects in sporadic tumors.
- Exploration of how understanding these defects can inform the application of targeted therapies.
Conclusions:
- Defects in homologous recombination repair are crucial in tumorigenesis and represent a viable therapeutic avenue.
- Expanding the focus to a general "repair-defective" phenotype, beyond BRCA mutations, can broaden therapeutic strategies.
- Identifying specific repair pathway dysfunctions in sporadic tumors is key to guiding the development and application of effective repair-directed therapies.
Related Concept Videos
01:20The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
01:20The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
01:12Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
01:12Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...